Griffin RJ - Search Results

1

Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk.

Hamzah RN, Alghazali KM, Biris AS, Griffin RJ. Hamzah RN, et al. Among authors: griffin rj. Int J Mol Sci. 2021 May 19;22(10):5346. doi: 10.3390/ijms22105346. Int J Mol Sci. 2021. PMID: 34069542 Free PMC article. Review.

2

Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics.

Shao J, Griffin RJ, Galanzha EI, Kim JW, Koonce N, Webber J, Mustafa T, Biris AS, Nedosekin DA, Zharov VP. Shao J, et al. Among authors: griffin rj. Sci Rep. 2013;3:1293. doi: 10.1038/srep01293. Sci Rep. 2013. PMID: 23443065 Free PMC article.

3

Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis.

Darrigues E, Nima ZA, Majeed W, Vang-Dings KB, Dantuluri V, Biris AR, Zharov VP, Griffin RJ, Biris AS. Darrigues E, et al. Among authors: griffin rj. Drug Metab Rev. 2017 May;49(2):212-252. doi: 10.1080/03602532.2017.1302465. Epub 2017 Jun 15. Drug Metab Rev. 2017. PMID: 28264609 Review.

4

Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment.

Darrigues E, Dantuluri V, Nima ZA, Vang-Dings KB, Griffin RJ, Biris AR, Ghosh A, Biris AS. Darrigues E, et al. Among authors: griffin rj. Drug Metab Rev. 2017 May;49(2):253-283. doi: 10.1080/03602532.2017.1307387. Epub 2017 Jun 19. Drug Metab Rev. 2017. PMID: 28298144

5

Modifying Dendritic Cell Activation with Plasmonic Nano Vectors.

Vang KB, Safina I, Darrigues E, Nedosekin D, Nima ZA, Majeed W, Watanabe F, Kannarpady G, Kore RA, Casciano D, Zharov VP, Griffin RJ, Dings RPM, Biris AS. Vang KB, et al. Among authors: griffin rj. Sci Rep. 2017 Jul 14;7(1):5513. doi: 10.1038/s41598-017-04459-1. Sci Rep. 2017. PMID: 28710434 Free PMC article.

6

Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models.

Koonce NA, Griffin RJ, Dings RPM. Koonce NA, et al. Among authors: griffin rj. Int J Mol Sci. 2017 Dec 9;18(12):2671. doi: 10.3390/ijms18122671. Int J Mol Sci. 2017. PMID: 29232825 Free PMC article.

7

Galectins as Molecular Targets for Therapeutic Intervention.

Dings RPM, Miller MC, Griffin RJ, Mayo KH. Dings RPM, et al. Among authors: griffin rj. Int J Mol Sci. 2018 Mar 19;19(3):905. doi: 10.3390/ijms19030905. Int J Mol Sci. 2018. PMID: 29562695 Free PMC article. Review.

8

Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems.

Jenkins SV, Nima ZA, Vang KB, Kannarpady G, Nedosekin DA, Zharov VP, Griffin RJ, Biris AS, Dings RPM. Jenkins SV, et al. Among authors: griffin rj. NPJ Precis Oncol. 2017 Sep 1;1(1):27. doi: 10.1038/s41698-017-0030-1. eCollection 2017. NPJ Precis Oncol. 2017. PMID: 29872709 Free PMC article.

9

Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma.

Jamshidi-Parsian A, Griffin RJ, Kore RA, Todorova VK, Makhoul I. Jamshidi-Parsian A, et al. Among authors: griffin rj. Exp Cell Res. 2018 Nov 1;372(1):16-24. doi: 10.1016/j.yexcr.2018.09.001. Epub 2018 Sep 8. Exp Cell Res. 2018. PMID: 30205087

10

Plasmonic Nanofactors as Switchable Devices to Promote or Inhibit Neuronal Activity and Function.

Alghazali KM, Hamzah RN, Nima ZA, Steiner R, Dhar M, Anderson DE, Hayar A, Griffin RJ, Biris AS. Alghazali KM, et al. Among authors: griffin rj. Nanomaterials (Basel). 2019 Jul 18;9(7):1029. doi: 10.3390/nano9071029. Nanomaterials (Basel). 2019. PMID: 31323847 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page